NHS Framework Agreement for Proprietary Pharmaceuticals - Interim 2015_3
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £200,000,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 18 Jun 2015 |
| Contract start | 1 Aug 2015 |
| Contract end | 31 Aug 2016 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-671914ca-adc8-11e6-9901-0019b9f3037b |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Please see attached spreadsheet - awarded suppliers | £190,000,000 | 21 Jul 2015 | active |
description
NHS Framework Agreement for Proprietary Pharmaceuticals - Interim 2015_3 Regions - London, Midlands and East, North of England, South of England
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 19 May 2015 | Award (award) | · | ocds-b5fd17-671914ca-adc8-11e6-9901-0019b9f3037b-65010-cm-phr-14-5451 |
more from DEPARTMENT OF HEALTH
- DoH - Action 17 Mental Health Strategy Community and Voluntary Sector Review · £130,000 · 17 Dec 2024
- ID 4345494 - Mental Health Champion Advertising Campaign · £420,000 · 9 Dec 2022
- ID 4231904 DAC55/22 - Stenography Services for Urology Services Inquiry and Muckamore Abbey Hospital Inquiry · 6 May 2022
- ID 4019972 - DoH - Provision of Audio Visual/Web Streaming Services and the Electronic Presentation of Evidence to support the Muckamore Abbey Hospital Inquiry and Urology Services Inquiry · £700,000 · 25 Apr 2022
- Care Provider Delivery Partner · £50,000 · 22 Jun 2021
- Herpes zoster (shingles) vaccines purchased, held centrally and distributed by the Department of Health in support of the immunisation programme · 21 May 2020
- Strategic stockpile of medicines 2021 · 21 May 2020
- HPV Vaccine (04-2021) · 30 Jan 2020
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.